The findings of our research are quite convincing, and thus the following conclusions can be drawn: the synthesised sulfonamide derivative S-1 as a CAIX inhibitor may provide a therapeutic option in cervical carcinoma by selectively targeting apoptotic pathways in the cancerous cervical cell line. This evidence concerns the gene CA9 and cervical carcinoma.